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Introduction
Macrophage activation syndrome (MAS), a severe com-
plication of systemic juvenile idiopathic arthritis (JIA)
and other inflammatory diseases, represents a one of the
most important rheumatological emergencies. Delayed
diagnosis could lead to life-threatening complications.
Pulmonary hemosiderosis (PH), possible seen at all ages
but most commonly among children, usually appears as
an idiopathic PH.
Objective
In this case report of a child with systemic JIA diag-
nosed at infancy, we aimed to analyze the results of
recurrent MAS attacks and to revise the patient’s clini-
cal course. The answer being sought in this presenta-
tion: does the high ferritin level, being increased
secondary to recurrent MAS attacks at a patient with
systemic JIA diagnosed at infancy, represent a reason for
the PH? Is there a need for further investigations of
MAS secondary hemosiderosis?
Case report
A 13 months old previously healthy infant, admitted to our
clinics because of high fever and rash. The fever showed an
intermittent course, lasting for two weeks. A physical
examination revealed a remarkable hepato-splenomegaly,
bilateral wrist and ankle arthritis and a maculopapular,
pink coloured rash being prominent especially during high
fever. In order to exclude the infectious diseases, viral and
bacterial infectious markers were tested and it was found
to be negative. A bone marrow biopsy was performed for
differential diagnosis of malignant or storage disease: no
depot cells or malignant cells were found in the bone
marrow.
A persistence of high fever was highly suggestive for sys-
temic JIA and MAS as its secondary complication. The
pulse steroid, cyclosporine (CYC) and anakinra were
induced in therapy. Diagnosis of systemic JIA secondary
MAS was a reason for hospitalization of patient about five
times during the one year follow up. During the hospitali-
zation of patient, a ferritin level was found to be as high as
120.990 ng/ml. Due to recurrent MAS attacks, a geneti-
cally investigation for familiar hemophagocytic lympho-
hystiocytosis was performed. The result was negative.
During the last hospitalization (2,5 years old patient), a
respiratory difficulties and diffuse infiltrations on chest
radiography, accompanied with a high ferritin level and
anemia were a reasons to consider a pulmonary hemosi-
derosis in a differential diagnosis of patient. Thoracic
tomography revealed a diffuse fibrous changes and a reti-
culo-nodular image in lung. Histochemical investigation
of broncho-alveolary lavage fluid by the ferrous stain
showed iron bearing macrophages. Thereby, a diagnosis
was pulmonary hemosiderosis secondary to MAS, one of
the most severe complications of systemic JIA.
The pulse steroid therapy was given in order to keep the
MAS attacks under control. Prednisone 15 mg/day, meth-
otrexate 5mg/week/oral route, CYC 50mg/day, anakinra
60 mg/day were used as a maintenance treatment.
Since the dyspnea became prominent during the clinical
course of the disease, patient was admitted to the intensive
care unit. At the time of discharge from the hospital,
patient remained dependent on oxygen therapy. Mentioned
1Istanbul University, Cerrahpasa Medical Faculty, Pediatric Rheumatology,
Istanbul, Turkey
Full list of author information is available at the end of the article
Barut et al. Pediatric Rheumatology 2015, 13(Suppl 1):P54
http://www.ped-rheum.com/content/13/S1/P54
© 2015 Barut et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://
creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
therapy resulted with patient’s good general status with no
high fever but the need for permanent oxygen therapy
continues.
Conclusion
Pulmonary hemosiderosis is being divided in a two main
grup: idiopathic (primary) and secondary PH. IPH is con-
sidered to be more common than secondary, which is
thought to be very rare. In the case of MAS, the most
important and the most destructive complication of SJIA,
ferritin could reach a very high level. Recently conducted a
multi-centric study among SJIA secondary MAS cases
showed a beginning ferritin level to be high as 8,325 ng/ml
(2,048-22,977 ng/ml). None of those cases had a clinical
presentation of pulmonary hemosiderosis.
Our patient with SJIA secondary MAS had a ferritin level
of 120.990 ng/ml. Prominent dyspnea, reticular image on
the chest radiography and anemia were suggestive for diag-
nosis of pulmonary hemosiderosis. Histochemical investi-
gation of broncho-alveolary lavage fluid by the ferrous
stain showing an iron bearing macrophages confirmed the
diagnosis of pulmonary hemosiderosis.
For the best of our knowledge, this is the first case of
pulmonary hemosiderosis secondary to MAS. In MAS
patients with high ferritin level, PH should be considering
as a possible complication.
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